Followers | 11 |
Posts | 196 |
Boards Moderated | 0 |
Alias Born | 07/26/2016 |
Thursday, January 19, 2017 9:27:43 AM
The study is with the National Institutes of Health.
The NIH is under the jurisdiction of the U.S. Dept of Health & Human Services. This is the description of their purpose from their own text:
Clinicaltrials.gov (note the .gov - only allowed to be used by the government) is the U.S. Dept of Health & Human Services trials website.
This is where OWCP's trial is being conducted.
Why not the FDA? Well, the FDA is in a bind as they're limited in what they can do due to marijuana currently being schedule 1 drug. They want to conduct research, though. Read this article: http://www.businessinsider.com/why-fda-believes-marijuana-is-no-medicine-2016-10as
Pertinant quote from the article:
Marijuana is a schedule 1 drug yet states are passing it for both medical and legal use. People are receiving it (legally) for medical use. Did the FDA approve that those people can receive it? Nope, but they do. The government doesn't care, wait until they declassify the drug and OWCP is the only company out there actually conducting legit trails with the US govt. It will be a tsunami.
Long story short? OWCP is completely legit. All of the research and details are out there in public view to see.
Look at the DD and make your own call.
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM